Synopsys Stock Today


USD 313.16  7.07  2.31%   

Market Performance
2 of 100
Odds Of Distress
Less than 1
Synopsys is selling at 313.16 as of the 28th of September 2022; that is 2.31 percent increase since the beginning of the trading day. The stock's lowest day price was 304.65. Synopsys has a very small chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Synopsys are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of August 2022 and ending today, the 28th of September 2022. Click here to learn more.
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company was incorporated in 1986 and is headquartered in Mountain View, California. Synopsys operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 152.91 M outstanding shares of which 2.03 M shares are at this time shorted by private and institutional investors with about 1.89 trading days to cover. More on Synopsys

Moving together with Synopsys

+0.77ADBEAdobe Systems Fiscal Year End 15th of December 2022 PairCorr
+0.88HDHome Depot TrendingPairCorr

Synopsys Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Synopsys' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Synopsys or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Synopsys is unlikely to experience financial distress in the next 2 years
Over 92.0% of the company shares are owned by institutional investors
Latest headline from Estimating The Fair Value Of Synopsys, Inc. - Simply Wall St
President Co-CEO, DirectorChiFoon Chan
Thematic IdeaSoftware (view all)
Average Analyst Recommendation
Analysts covering Synopsys report their recommendations after researching Synopsys' financial statements, talking to executives and customers, or listening in on Synopsys' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Synopsys. The Synopsys consensus assessment is calculated by taking the average forecast from all of the analysts covering Synopsys.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Synopsys' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Synopsys (SNPS) is traded on NASDAQ Exchange in USA and employs 16,361 people. The company currently falls under 'Large-Cap' category with current market capitalization of 46.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Synopsys's market, we take the total number of its shares issued and multiply it by Synopsys's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Synopsys conducts business under Technology sector and is part of Software—Infrastructure industry. The entity has 152.91 M outstanding shares of which 2.03 M shares are at this time shorted by private and institutional investors with about 1.89 trading days to cover. Synopsys currently holds about 1.53 B in cash with 1.72 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01.
Check Synopsys Probability Of Bankruptcy
Synopsys shows a total of one hundred fifty-two million nine hundred ten thousand outstanding shares. The majority of Synopsys outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Synopsys to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Synopsys. Please pay attention to any change in the institutional holdings of Synopsys as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Synopsys Ownership Details

Synopsys Stock Price Odds Analysis

In regard to a normal probability distribution, the odds of Synopsys jumping above the current price in 90 days from now is about 81.59%. The Synopsys probability density function shows the probability of Synopsys stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Synopsys has a beta of 0.9386. This usually implies Synopsys market returns are sensible to returns on the market. As the market goes up or down, Synopsys is expected to follow. Additionally, the company has an alpha of 0.0688, implying that it can generate a 0.0688 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 313.16HorizonTargetOdds Above 313.16
18.30%90 days
Based on a normal probability distribution, the odds of Synopsys to move above the current price in 90 days from now is about 81.59 (This Synopsys probability density function shows the probability of Synopsys Stock to fall within a particular range of prices over 90 days) .

Synopsys Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Synopsys market risk premium is the additional return an investor will receive from holding Synopsys long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Synopsys. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Synopsys' alpha and beta are two of the key measurements used to evaluate Synopsys' performance over the market, the standard measures of volatility play an important role as well.

Synopsys Stock Against Markets

Picking the right benchmark for Synopsys stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Synopsys stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Synopsys is critical whether you are bullish or bearish towards Synopsys at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Synopsys without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Backtesting Now


Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Synopsys Corporate Directors

Synopsys corporate directors refer to members of a Synopsys board of directors. The board of directors generally takes responsibility for the Synopsys' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Synopsys' board members must vote for the resolution. The Synopsys board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Alfred Castino - Independent DirectorProfile
Deborah Coleman - Independent DirectorProfile
Chrysostomos Nikias - Independent DirectorProfile
Janice Chaffin - DirectorProfile

Invested in Synopsys?

The danger of trading Synopsys is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Synopsys is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Synopsys. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Synopsys is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at World Market Map. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for analysis

When running Synopsys price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Synopsys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synopsys. If investors know Synopsys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synopsys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Synopsys is measured differently than its book value, which is the value of Synopsys that is recorded on the company's balance sheet. Investors also form their own opinion of Synopsys' value that differs from its market value or its book value, called intrinsic value, which is Synopsys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synopsys' market value can be influenced by many factors that don't directly affect Synopsys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synopsys' value and its price as these two are different measures arrived at by different means. Investors typically determine Synopsys value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synopsys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.